Clamp-crushing vs. radiofrequency-assisted liver resection: Changes in liver function tests

Hepato-Gastroenterology

Volumn 59, Issue 115, 2012, Pages 800-804

  Palibrk, Ivan ^a,b   Milicic, Biljana ^a,b   Stojiljkovic, Ljuba ^c   Manojlovic, Nebojsa ^d   Dugalic, Vladimir ^a   Bumbasirevic, Vesna ^a,b   Kalezic, Nevena ^a,b   Zuvela, Marinko ^a   Milicevic, Miroslav ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b CLINICAL CENTER OF SERBIA   (Serbia)

^c NORTHWESTERN UNIVERSITY   (United States)

^d UNIVERSITY OF DEFENCE   (Serbia)

Author keywords

Liver function parameters; Liver resection

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; LIDOCAINE;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CLAMP CRUSHING TECHNIQUE; CLINICAL ARTICLE; FEMALE; HUMAN; INTERMETHOD COMPARISON; INTERNATIONAL NORMALIZED RATIO; LIVER FUNCTION; LIVER INJURY; LIVER NECROSIS; LIVER RESECTION; MALE; PERIOPERATIVE PERIOD; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTHROMBIN TIME; QUANTITATIVE ANALYSIS; RADIOFREQUENCY ABLATION; SURGICAL TECHNIQUE;

AGED; ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; CATHETER ABLATION; CHI-SQUARE DISTRIBUTION; CONSTRICTION; FEMALE; HEPATECTOMY; HUMANS; LIVER; LIVER DISEASES; LIVER FUNCTION TESTS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RISK ASSESSMENT; RISK FACTORS; SERBIA; TIME FACTORS; TREATMENT OUTCOME;

EID: 84860513078     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: 10.5754/hge11539     Document Type: Article

References (34)

1. Hanazaki K, Kajikawa S, Shimozawa N, et al.: Hepatic resection for large hepatocellular carcinoma. Am J Surg 2001; 181:347-353. (Pubitemid 32595682)
2. Mullen JT, Ribero D, Reddy SK, et al.: Hepatic insufficiency and mortality in 1,059 noncirrhotic patients undergoing major hepatectomy. J Am Coll Surg 2007; 204:854-862. (Pubitemid 46661186)
3. Capussotti L, Muratore A, Amisano M, et al.: Liver resection for hepatocellular carcinoma on cirrhosis: Analysis of mortality, morbidity and survival-a european single center experience. Eur J Surg Oncol 2005; 31:986-993. (Pubitemid 41671112)
4. Lesurtel M, Selzner M, Petrowsky H, McCormack L, Clavien PA: How should transection of the liver be performed?: A prospective randomized study in 100 consecutive patients: Comparing four different transection strategies. Ann Surg 2005; 242:814-822.
5. Rau HG, Duessel AP, Wurzbacher S: The use of water-jet dissection in open and laparoscopic liver resection. HPB (Oxford) 2008; 10:275-280.
6. Ayav A, Bachellier P, Habib NA, et al.: Impact of radiofrequency assisted hepatectomy for reduction of transfusion requirements. Am J Surg 2007; 193:143-148. (Pubitemid 46111027)
7. Melendez JA, Arslan V, Fischer ME, et al.: Perioperative outcomes of major hepatic resections under low central venous pressure anesthesia: Blood loss, blood transfusion, and the risk of postoperative renal dysfunction. J Am Coll Surg 1998; 187:620-625. (Pubitemid 28557801)
8. Milicevic M, Bulajic P, Zuvela M, et al.: A radiofrequency-assisted minimal blood loss liver parenchyma dissection technique. Dig Surg 2007; 24:306-313. (Pubitemid 47174048)
9. Teratani T, Yoshida H, Shiina S, et al.: Radiofrequency ablation for hepatocellular carcinoma in so-called high-risk locations. Hepatology 2006; 43:1101-1108. (Pubitemid 43724634)
10. Delis SG, Bakoyiannis A, Tassopoulos N, Athanasiou K, Madariaga J, Dervenis C: Radiofrequency-assisted liver resection. Surg Oncol 2008; 17:81-86. (Pubitemid 351508400)
11. Kamiyama T, Nakanishi K, Yokoo H, et al.: Perioperative management of hepatic resection toward zero mortality and morbidity: Analysis of 793 consecutive cases in a single institution. J Am Coll Surg 2010; 211:443-449.
12. Dimick JB, Cowan JA, Jr., Knol JA, Upchurch GR Jr: Hepatic resection in the United States: Indications, outcomes, and hospital procedural volumes from a nationally representative database. Arch Surg 2003; 138:185-191. (Pubitemid 36221339)
13. Asiyanbola B, Chang D, Gleisner AL, et al.: Operative mortality after hepatic resection: Are literature-based rates broadly applicable? J Gastrointest Surg 2008; 12:842-851.
14. Virani S, Michaelson JS, Hutter MM, et al.: Morbidity and mortality after liver resection: Results of the patient safety in surgery study. J Am Coll Surg 2007; 204:1284-1292. (Pubitemid 46819089)
15. Seyama Y, Kokudo N: Assessment of liver function for safe hepatic resection. Hepatol Res 2009; 39:107-116.
16. Garcea G, Ong SL, Maddern GJ: Predicting liver failure following major hepatectomy. Dig Liver Dis 2009; 41:798-806.
17. Wu CC, Ho WL, Yeh DC, et al.: Hepatic resection of hepatocellular carcinoma in cirrhotic livers: Is it unjustified in impaired liver function? Surgery 1996; 120:34-39.
18. Mitsuo M, Takahiro T, Yasuko T, et al.: Radiofrequency (rf)-assisted hepatectomy may induce severe postoperative liver damage. World J Surg 2007; 31:2208-2212.
19. Vanagas T, Gulbinas A, Pundzius J, Barauskas G: Radiofrequency ablation of liver tumors (i): Biological background. Medicina (Kaunas) 2010; 46:13-17.
20. Winbladh A, Sandstrom P, Olsson H, Svanvik J, Gullstrand P: Segmental ischemia of the liver-microdialysis in a novel porcine model. Eur Surg Res 2009; 43:276-85.
21. Rahbari NN, Garden J, Padbury R, et al.: Post-hepatectomy liver failure: A definition and grading by the International Study Group of Liver Surgery (ISGLS). Surgery 2011; 149:713-724.
22. Iwata T, Inoue K, Nishiyama N, et al.: Factors predicting early postoperative liver cirrhosis-related complications after lung cancer surgery in patients with liver cirrhosis. Interact Cardiovasc Thorac Surg 2007; 6:720-730. (Pubitemid 350291684)
23. Balzan S, Belghiti J, Farges O, et al.: The "50-50 criteria" On postoperative day 5: An accurate predictor of liver failure and death after hepatectomy. Ann Surg 2005; 242:824-828.
24. Delis S, Bakoyiannis A, Tassopoulos N, et al.: Clamp-crush technique vs. Radiofrequency-assisted liver resection for primary and metastatic liver neoplasms. HPB (Oxford) 2009; 11:339-344.
25. Kuroda H, Kasai K, Kakisaka K, et al.: Changes in liver function parameters after percutaneous radiofrequency ablation therapy in patients with hepatocellular carcinoma. Hepatol Res; 40:550-554.
26. Xu D, Zalmas LP, La Thangue NB: A transcription cofactor required for the heat-shock response. EMBO Rep 2008; 9:662-669. (Pubitemid 351927687)
27. Chowdhury S, Ragaz C, Kreuger E, Narberhaus F: Temperature-controlled structural alterations of an RNA thermometer. J Biol Chem 2003; 278:47915-47921. (Pubitemid 37523240)
28. Vincent JL, Dubois MJ, Navickis RJ, Wilkes MM: Hypoalbuminemia in acute illness: is there a rationale for intervention? Ann Surg 2003; 237:319-334.
29. Wilkers MW, Navickis RJ: Patient survival after human albumin administration. A meta- analysis of randomized, controlled trials. Ann Intern Med.2001; 135:149-164.
30. Haynes GR, Navickis RJ, Wilkes MM: Albumin administration - what is the evidence of clinical benefit? A systematic review of randomized controlled trials. Eur J Anaesthesiol 2003; 20:771-93. (Pubitemid 37236932)
31. Tamasi V, Kiss A, Dobozy O, et al.: The effect of dexamethasone on p450 activities in regenerating rat liver. Biochem Biophys Res Commun 2001; 286:239-242. (Pubitemid 32924904)
32. Jochum C, Beste M, Penndorf V, et al.: Quantitative liver function tests in donors and recipients of living donor liver transplantation. Liver Transpl 2006; 12:544-549.
33. Verbeeck RK: Pharmacokinetics and dosage adjustment in patients with hepatic dysfunction. Eur J Clin Pharmacol 2008; 64:1147-1161.
34. Waller ES: Pharmacokinetic principles of lidocaine dosing in relation to disease state. J Clin Pharmacol 1981; 21:181-194.